Clinical Trials Browser

Unknown × Neoplasms, Second Primary × Clear all

NCT06291688 2024-03-04

Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability

Phase NA Unknown

Neoplasms, Neoplasms, Second Primary, Drug-Related Side Effects and Adverse Reactions

NCT04776005 2024-01-03

COVIDVAC OH

Other hematologic neoplasm

COVID-19, Neoplasms, Second Primary, Hematologic Neoplasms

NCT05768256 2023-04-05

MBCT

Phase NA Unknown

Cancer Pain, Neoplasms, Neoplasms, Second Primary

NCT05322486 2022-04-11

Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases

Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms, Neoplasms, Second Primary

NCT04195217 2021-12-17

ARONCO

Phase NA Unknown

Neoplasms, Neoplasms, Second Primary

NCT04864717 2021-09-08

Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI

Phase 4 Unknown

Neoplasms, Second Primary, Acneiform Eruptions

NCT03377829 2021-03-19

A Multicenter Trial of PLA vs. Surgery for Treating PTMC

Phase NA Unknown

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms, Neoplasms, Second Primary

NCT03475979 2020-11-30

Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing

Breast Neoplasms, Neoplasms, Second Primary

NCT03413865 2019-02-15

Telemedicine Clinic for Prostate Cancer Patients

Phase NA Unknown

Neoplasms, Second Primary

NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Phase 4 Unknown

Neoplasms, Neoplasms, Second Primary

NCT02523495 2018-08-07

The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer

Neoplasms, Second Primary

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase 4 Unknown

Neoplasms, Second Primary